Christian Stach, MD

UCB Biosciences GmbH
Monheim am Rhein, Germany

Current Position: Senior Medical Director, Clinical Lead Dapirolizumab pegol, UCB
Since 2009: UCB Biosciences
2001-2009: University of Erlangen
2000-2001: University of Munich
1992-1999: University of Erlangen

Presentation(s):

• 2333: Dapirolizumab Pegol Impacts Important Immunologic Pathways in SLE: Pharmacodynamic Analysis of B Cell and Type I Interferon Pathways from a Phase 2b Trial

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.